Tag: Ultragenyx
Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate

Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate

NOVATO, California, TOKYO and LONDON, May 17, 2018 /PRNewswire/ -- Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to 6% of Patients ...

Lees verder
Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X-Linked Hy

Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X-Linked Hy

TOKYO, LONDON and NOVATO, California, February 23, 2018 /PRNewswire/ -- Crysvita is the First Treatment for XLH that Targets the Underlying Cause of the Disease Crysvita ...

Lees verder
Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children

Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children

TOKYO, LONDON, and NOVATO, California, December 15, 2017 /PRNewswire/ -- If approved, burosumab would be the first targeted disease-modifying treatment for XLH   Kyowa Hakko ...

Lees verder
BizPress.nl